NCT05313815View on ClinicalTrials.gov

Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2030

Conditions
Prostate Cancer
Interventions
RADIATION

Moderate hypofractionated boost to the prostate with pelvic RT (external beam radiotherapy)

External beam radiotherapy- 60 Gy in 20 fractions to the prostate, 48 Gy in 20 fractions to the pelvis, 68 Gy in 20 fraction optional boost to prostatic dominant intraprostatic lesion, 55 Gy in 20 fraction optional boost to involved pelvic lymph nodes

Trial Locations (1)

M5G 2M9

RECRUITING

Princess Margaret Cancer Center, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER